Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Stewart

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Critical Reviews in Oncology/Hematology|March 6, 2007
Mechanisms of resistance to cisplatin and carboplatinDavid J Stewart
The Oncologist|June 5, 2024
Has the blood-brain barrier finally been busted?David J Stewart
Journal of the National Cancer Institute|December 7, 2013
Wnt signaling pathway in non-small cell lung cancerDavid J Stewart
Journal of the National Cancer Institute|August 2, 2014
ResponseDavid J Stewart
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Chemotherapy dose intensity and survival in non-small cell lung cancerDavid J Stewart
Journal of the National Cancer Institute|March 13, 2008
Re: Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non-small cell lung cancerDavid J Stewart
The Oncologist|July 10, 2024
It is time to rethink randomized clinical trial approachesDavid J Stewart
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Randomized phase II trials: misleading and unreliableDavid J Stewart
The Oncologist|December 24, 2004
Topotecan in the first-line treatment of small cell lung cancerDavid J Stewart
The Oncologist|December 24, 2004
Update on the role of topotecan in the treatment of non-small cell lung cancerDavid J Stewart
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Critical Reviews in Oncology/Hematology|March 6, 2007
Mechanisms of resistance to cisplatin and carboplatinDavid J Stewart
The Oncologist|June 5, 2024
Has the blood-brain barrier finally been busted?David J Stewart
Journal of the National Cancer Institute|December 7, 2013
Wnt signaling pathway in non-small cell lung cancerDavid J Stewart
Journal of the National Cancer Institute|August 2, 2014
ResponseDavid J Stewart
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Chemotherapy dose intensity and survival in non-small cell lung cancerDavid J Stewart
Journal of the National Cancer Institute|March 13, 2008
Re: Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non-small cell lung cancerDavid J Stewart
The Oncologist|July 10, 2024
It is time to rethink randomized clinical trial approachesDavid J Stewart
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Randomized phase II trials: misleading and unreliableDavid J Stewart
The Oncologist|December 24, 2004
Topotecan in the first-line treatment of small cell lung cancerDavid J Stewart
The Oncologist|December 24, 2004
Update on the role of topotecan in the treatment of non-small cell lung cancerDavid J Stewart
Pageof 16